Referências bibliográficas

1. Semaglutida (Ozempic/Wegovy) — eficácia e perfil do tratamento

Wilding JPH, Batterham RL, Calanna S, et al., for the STEP 1 Study Group. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384:989-1002.

2. Tirzepatida (Mounjaro/Zepbound) — eficácia e perfil do tratamento

Jastreboff AM, Aronne LJ, Ahmad NN, et al., for the SURMOUNT-1 Investigators. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387:205-216.

3. Perda de massa magra durante tratamento com GLP-1 — revisão sistemática

Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition: systematic review and network meta-analysis. Metabolism. 2024.

4. Queda de cabelo (eflúvio telógeno) associada a emagrecimento

Telogen Effluvium Associated With Weight Loss: A Single Center Retrospective Study. Ann Dermatol. 2024.

5. Treinamento de força e proteína na preservação de massa muscular

Nutritional and exercise interventions in individuals with sarcopenic obesity around retirement age: a systematic review and meta-analysis. 2023.

6. Recomendações de proteína e exercício na obesidade sarcopênica

Exercise and Protein Supplementation Recommendations for Older Adults With Sarcopenic Obesity: A Meta-Review. 2023.

7. Posicionamento brasileiro sobre tratamento farmacológico da obesidade

Pharmacologic Treatment of Obesity in Adults and Its Impact on Comorbidities: 2024 Update and Position Statement of Specialists from ABESO and SBEM.

8. Diretrizes brasileiras de obesidade (portal oficial)

Associação Brasileira para o Estudo da Obesidade e da Síndrome Metabólica (ABESO). Diretrizes.